Celebrating 10 years of RNAi innovation (2006-2016)

RNA interference (RNAi) is a natural process where small RNA molecules inhibit gene expression by targeting specific messenger RNA molecules for degradation or translation repression, regulating gene expression. It's like a molecular switch that turns genes off, helping cells control which genes are active and how much of their proteins are made.

In 2006, Andrew Fire and Craig Mello won the Nobel Prize for Physiology or Medicine for their discovery of RNAi. This discovery led to the foundation for Alnylam Pharmaceuticals’ clinical pipeline where the power of RNAi could be harnessed to target certain rare diseases, such as hereditary ATTR amyloidosis.

The tenth anniversary of this Nobel Prize award in 2016 inspired the development of a corporate brand awareness campaign. This campaign was intended to share Alnylam’s research and development story more broadly and prepare the market for the eventual commercialization of its first product: patisiran.

I designed a campaign styleguide, microsite, motion graphics and social media to promote the initiative. I also collaborated with a video production vendor to film a series of videos that outlined the story of Alnylam from its conception to where the business stood in 2016.

Content developed for this campaign continues to live on through Alnylam’s corporate media channels and website.